第76回 日本循環器学会学術集会

美甘レクチャー
座長:
Tsuguya Sakamoto (Hanzomon Hospital, Tokyo)
ML. Aortic Stenosis in the Elderly: Diagnosis and Management
Pravin M. Shah (Hoag Heart and Vascular Institute, Newport Beach, USA)
真下記念講演
座長:
矢﨑 義雄 (独立行政法人国立病院機構)
MML. 真下記念講演
鈴木 章 (北海道大学 名誉教授)
100歳記念講演
座長:
杉本 恒明 (関東中央病院 名誉院長)
MLC. A Message to My Younger Peers - What I Have Learned over a Lifetime -
日野原 重明 (聖路加国際病院)
会長講演
座長:
松﨑 益德 (山口大学 器官病態内科学)
CCL. Holistic Medical Care for Patients with Heart Failure
鄭 忠和 (鹿児島大学 循環器・呼吸器・代謝内科学)
特別講演
SL1. 特別講演 1
座長:
Saichi Hosoda (Japan Research Promotion Society for Cardiovascular Diseases, Tokyo)
SL1. Adventures in Cardiovascular Research
Eugene Braunwal (Harvard Medical School, Boston, USA)
SL2. 特別講演 2
座長:
Ryozo Nagai (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo)
SL2. Regulation of Myocardial Survival and Death by Autophagy during Ischemia and Reperfusion
Junichi Sadoshima (University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, USA)
SL3. 特別講演 3
座長:
Toyoaki Murohara (Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya)
SL3. Inflammation and Vascular Injury: Basic Discovery to Drug Development
Daniel I. Simon (University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, USA)
SL4. 特別講演 4
座長:
Hiroyuki Tsutsui (Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo)
SL4. Innovative Natriuretic Peptide Therapeutics for Cardiovascular Disease
John C. Burnett (Mayo Clinic, Rochester, USA)
SL5. 特別講演 5
座長:
Hiroaki Shimokawa (Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai)
SL5. Heart Failure in the 21st Century : Challenges and Progresses
Michel Komajda (Hopital Pitie Salpetriere, Department de Cardiologie, Paris, France)
※こちらの演題は収録しておりません。
SL6. 特別講演 6
座長:
Kazutaka Aonuma (Cardiovascular Division, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki)
SL6. Current Concepts and Management of Brugada Syndrome; Two Decades of Progress
Koonlawee Nademanee (Pacific Rim Electrophysiology Research Institute, Los Angeles, USA)
SL7. 特別講演 7
座長:
Hiroshi Kasanuki (Faculty of Science and Engineering Integrated Bioscience and Biomedical Engineering, Waseda University, Tokyo)
SL7. Update in Brugada Syndrome
Josep Brugada (Hospital Clinic de Barcelona, Barcelona, Spain)
SL8. 特別講演 8
座長:
Kyoichi Mizuno (Division of Cardiology, Department of Internal Medicine, Nippon Medical School, Tokyo)
SL8. Endothelial Function from Bench to Clinical Practic
Amir Lerma (Cardiovascular Disease, Mayo Graduate School of Medicine, Mayo Clinic, Rochester, USA)
SL9. 特別講演 9
座長:
Tetsu Yamaguchi (Toranomon Hospital, Tokyo)
SL9. Principal physiological and medical problems of the long-term space mission. Personal experience
Oleg Atkov (Health and Public Organizations, JSC "Russian Railways", Moscow, Russia)
SL10. 特別講演 10
座長:
Kiyoshi Yoshida (Department of Cardiology, Kawasaki Medical School, Okayama)
SL10. Ventriculo-vascular Interaction
Namsik Chung (Severance Cardiovascular Hospital, Yonsei Universtiy, Seoul, Korea)
SL11. 特別講演 11
座長:
Hirohide Matsuo (Professor Emeritus, Kagawa University, Faculty of Medicine, Kagawa)
SL11. Practical Approach to Using Strain Echocardiography to Evaluate the Left Ventricle
Harvey Feigenbaum (Indiana University School of Medicine, Indianapolis, USA)
SL12. 特別講演 12
座長:
Junichi Yoshikawa (Nishinomiya Watanabe Cardiovascular Center, Hyogo)
SL12. Left Ventricular Non Compaction: 25 Years Odyssey
A. Jamil Tajik (Aurora Cardiovascular Care / Cardiac Specialty Center, Aurora St. Luke's Medical Center, Milwaukee, USA)
招待講演
IL1. 招待講演 1
座長:
Shigetake Sasayama (Department of Life and Medical Sciences, Doshisha University, Kyoto)
IL1. Sympathetic Hyperactivity Activity. Implications for Cardiovascular and Metabolic Diseases
Finn Waagstein (Sahlgrenska University Hospital, Goteborg, Sweden)
IL2. 招待講演 2
座長:
Issei Komuro (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka)
IL2. Tissue Specific Adult Stem Cell
Piero Anversa (Brigham and Women's Hospital, Harvard Medical School, Boston, USA)
※こちらの演題は収録しておりません。
IL3. 招待講演 3
座長:
Jong-Hoa Bae (Department of Cardiovascular Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea)
IL3. Integrated Cardiovascular Imaging
Jae K. Oh (Mayo Clinic, Rochester, USA)
16th Asian-Pacific Congress on Doppler and Echocardiography
APCDE-LEC1. APCDE Lecture 1
座長:
Tsuguya Sakamoto (Hanzomon Hospital, Tokyo)
APCDE-LEC1. Many Faces of SAM: Mechanisms and Management
Pravin M. Shah (Hoag Heart and Vascular Institute, Newport Beach, USA)
APCDE-LEC2. APCDE Lecture 2
座長:
Oleg Atkov (Health and Public Organizations, JSC "Russian Railways", Moscow, Russia)
APCDE-LEC2. Apical Hypertrophic Cardiomyopathy: A Quarter Century Follow-up with Reference to the Eventful as well as Uneventful Natural Courses
Tsuguya Sakamoto (Hanzomon Hospital, Tokyo)
APCDE-SY1. APCDE Symposium 1
座長:
Harvey Feigenbaum (Indiana University School of Medicine, Indianapolis, USA)
Pravin M. Shah (Hoag Heart and Vascular Institute, Newport Beach, USA)
APCDE-SY1-KEY. Keynote Lecture:A Practical Approach to Using Strain Echocardiography to Evaluate the Left Ventricle
Harvey Feigenbaum (Indiana University School of Medicine, Indianapolis, USA)
APCDE-SY1-1. Visualizing Estimation of Intra-ventricular Blood Flow Structure in Heart Failure by Echo-dynamography
Motonao Tanaka (Honorary Director, Cardiovascular Center, Tohoku Welfare Pension Hospital, Miyagi)
APCDE-SY1-2. Diastolic Heart Failure: What We Learned from Echo Doppler Studies in Rats
Tohru Masuyama (Cardiovascular Division, Hyogo College of Medicine, Nishinomiya)
APCDE-SY1-3. Study of Left Ventricular Systolic Function in Patients with Chronic Heart Failure Using Vector Flow Mapping
Jiawei Tian (Ultrasound Department, 2nd Hospital Affiliated to Harbin Medical University, Harbin, China)
APCDE-SY1-4. Left Atrial Reverse Remodeling and Outcome in Patients with Heart Failure
Kazuaki Tanabe (Department of Cardiology, Shimane University Faculty of Medicine, Izumo)
APCDE-SY1-5. Assessment for Sequence of Systole and Diastole between Left and Right Ventricle with Pulse Doppler Echocardiography in Normal Subjects
Tian Gang Zhu (Peking University People's Hospital, Beijing, China)
APCDE-SY2. APCDE Symposium 2
座長:
Jong-Hoa Bae (Department of Cardiovascular Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea)
Junichi Yoshikawa (Nishinomiya Watanabe Cardiovascular Center, Hyogo)
APCDE-SY2-KEY. Keynote Lecture:Echocardiography in Heart Failure: From Diagnosis to Clinical Trial
Jae K. Oh (Mayo Clinic, Rochester, USA)
APCDE-SY2-1. Accuracy of Echocardiographic Estimation of Left Ventricular Relaxation and Filling Pressure: A Multicenter Study in Japan (SMAP)
Satoshi Yamada (Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo)
APCDE-SY2-2. Role of Echocardiography in Atrila Fibrillation
Namsik Chung (Yonsei Cardiovascular Hospital, Yonsei University, Seoul, Korea)
APCDE-SY2-3. The Implementation of Speckle-tracking Technique in the MAGNET (Mitochondria-AGing in Northern Taiwan) Study: A Community-based Cohort in Northern Taiwan
Chung-Lieh Hung (Mackay Memorial Hospital, Taipei, Taiwan)
※こちらの演題は収録しておりません。
APCDE-SY2-4. Assessment of Pulmonary Hypertension Using Cardiac Time Interval Analysis
Toshinori Yuasa (Department of Cardiovascular, Respiratory and Metabolic Medicine, School of Medicine, Kagoshima University, Kagoshima)
APCDE-SY3. APCDE Symposium 3
座長:
Sam-Soo Kim (Cardiovascular Center, Sung Ae Cardiovascular Center, Seoul, Korea)
Hirohide Matsuo (Professor Emeritus, Kagawa University, Faculty of Medicine, Kagawa)
APCDE-SY3-KEY. Keynote Lecture:Diastology 2012: 30 Years of Deciphering Doppler "Rosetta Stone"
A. Jamil Tajik (Aurora Cardiovascular Care / Cardiac Specialty Center, Aurora St. Luke's Medical Center, Milwaukee, USA)
APCDE-SY3-1. From the Assessment of LV Filling Pressure to That of Diastolic Function
Kazuhiro Yamamoto (Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University, Yonago)
APCDE-SY3-2. Role of Echocardiography in Diastolic Heart Failure
Jong-Won Ha (Yonsei University College of Medicine, Seoul, Korea)
APCDE-SY3-3. Assessment of Systolic Function Using Speckle Tracking Echocardiography
Satoshi Nakatani (Department of Functional Diagnostics, Osaka University Graduate School of Medicine, Suita)
APCDE-SY3-4. Mechanical Discoordination for Predicting Response to Cardiac Resynchronization Therapy: Moving beyond Dyssynchrony
Chun-Li Wang (Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan)
APCDE-SY4. APCDE Symposium 4
座長:
Tsui-Lieh Hsu (Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan)
Jong-Chun Park (The Heart Center of Chonnam National University Hospital, Gwangju, Korea)
APCDE-SY4-KEY. Keynote Lecture:Echo Doppler Stress Testing for Aortic Stenosis
Catherine M. Otto (University of Washington School of Medicine, Seattle, USA)
APCDE-SY4-1. Tissue Doppler and Strain Imaging in Mitral Regurgitation
Lieng H. Ling (National University Heart Centre, Singapore)
APCDE-SY4-2. Dynamic Tethering: Role of Exercise Stress Echocardiography for Ischemic Mitral Regurgitation and Functional Mitral Stenosis
Yutaka Otsuji (Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu)
APCDE-SY4-3. Role of Closing Force in Ischemic MR: Anterior vs. Inferior MI
Jun Kwan (Inha University Hospital, Inchon, Korea)
APCDE-SY4-4. Aortic Regurgitation -Role of Transesophageal Echocardiography for Anatomical and Functional Assessment-
Hiroya Kawai (Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe)
APCDE-SY5. APCDE Symposium 5
座長:
Cheuk-Man Yu (Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Institute of Vascular Medicine, and S.H. Ho Cardiovascular and Stroke Centre, The Chinese University of Hong Kong, Hong Kong)
Kunio Miyatake (Yoshida-Onohara Higashi Clinic, Osaka)
APCDE-SY5-KEY. Keynote Lecture:Impact of Dyssynchrony and Myocardial Function Reserve in Heart Failure with Preserve Ejection Fraction
Cheuk-Man Yu (Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Institute of Vascular Medicine, and S.H. Ho Cardiovascular and Stroke Centre, The Chinese University of Hong Kong, Hong Kong)
APCDE-SY5-1. Intravascular Ultrasound Evaluation of Plaque Progression and Regression
Masakazu Yamagishi (Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa)
APCDE-SY5-2. Vulnerable Plaques: State of the Art
Yun Zhang (Department of Cardiology, Shandong University Qilu Hospital, Jinan, China)
APCDE-SY5-3. Changing Spectrum of CAD : Coronary Echogram in the World Today
Ho-Joong Youn (The Catholic University of Korea, Seoul, Korea)
APCDE-SY5-4. Usefulness of Coronary Flow Velocity Assessment in Coronary Artery Disease
Takashi Akasaka (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama)
APCDE-SY6. APCDE Symposium 6
座長:
Jae Hyung Kim (Department of Cardiology, St. Paul Hospital, The Catholic University of Korea, Seoul, Korea)
Katsu Takenaka (Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo)
APCDE-SY6-KEY. Keynote Lecture:Role of Echocardiography in the Era of Catheter Procedure
Takahiro Shiota (Cedars-Sinai Medical Center / UCLA (University of California, Los Angeles), Los Angeles, USA)
APCDE-SY6-1. Atrial Sensing is the Optimal Setting in Patients on Cardiac Resynchronization Therapy Assessed by Tissue Doppler Imaging
Hsin-Yueh Liang (China Medical University Hospital, Taichung, Taiwan)
APCDE-SY6-2. Non-linear Time Varying Elastance Model May Explain "Postsystolic Shortening" of Acute Ischemic Myocardium
Makoto Akaishi (Department of Cardiology, Kitasato Institute Hospital, Tokyo)
APCDE-SY6-3. Clinical Application of Pocket-size Cardiac Ultrasound: A Symbol of Smart Cardiologist
Tsui-Lieh Hsu (Taipei Veterans General Hospital, Taipei, Taiwan)
APCDE-SY6-4. Early Impairment and Its Compensation of Left Ventricular Diastolic and Systolic Function: Evaluation by Two-dimensional Speckle-tracking Echocardiography
Takashi Oki (Cardiovascular Section, Higashi Tokushima Medical Center, National Hospital Organization, Tokushima)
APCDE-SY7. APCDE Symposium 7
座長:
Hao Wang (Department of Echocardiography Fu Wai Hospital, Beijing, China)
Soon-Pyo Hong (Cardiovascular Center, Department of Internal Medicine, Chosun University Hospital, Gwangju, Korea)
APCDE-SY7-KEY. Keynote Lecture:Echocardiographer as a Clinician: Diagnosis beyond Images
Dae-Won Sohn (Seoul National University College of Medicine, Seoul, Korea)
APCDE-SY7-1. How to Improve Left Ventricular Diastolic Function in Patients with Diastolic Dysfunction. Lesson from Our Multicenter Trials
Hiroshi Ito (Division of Cardiovascular Medicine, Okayama University School of Medicine, Okayama)
APCDE-SY7-2. Interesting Doppler Tracing Including Artifacts
Jae-Kwan Song (Asan Medical Center, Seoul, Korea)
APCDE-SY7-3. Visualization and Quantification of Intracardiac Fluid Field and Fluid Dynamics Using Ultrasonic VFM Techniques
Lixue Yin (Key Laboratory of Ultrasound in Cardiac Electrophysiology and Bio-mechanics, Institute of Ultrasound in Medicine, Sichuan Academy of Medical Sciences & Sichuan Porvincial Peoples Hospital, Chengdu, China)
APCDE-SY7-4. Visualization of Left Ventricular Suction and Its Role in Diastology
Nobuyuki Ohte (Department of Cardio-Renal Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya)
APCDE-IIC. APCDE International Interesting Cases
座長:
Bang-Hun Lee (Heart Disease and Hypertension Clinic, Director of Adult Disease Center, Songdo Hospital, Seoul, Korea)
Yoshiyuki Hada (Sakakibara Memorial Clinic, Tokyo)
Kiyoshi Yoshida (Department of Cardiology, Kawasaki Medical School, Okayama)
Jin-Won Jeong (Division of Cardiology, Wonkwang University School of Medicine, Iksan, Korea)
APCDE-IIC-1. Width is Better than Height
Kyoung-Sig Chang (Chosun University Hospital, Kwangju, Korea)
APCDE-IIC-2. A Rare Case of Partial Anomalous Pulmonary Venous Return
Masumi Iwai-Takano (Intensive Care Unit, Fukushima Medical University Hospital, Fukushima)
APCDE-IIC-3. Progressive Pseudoaneurysm of the Left Ventricle
Won-Ho Kim (Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, Korea)
APCDE-IIC-4. Restrictive Left Ventricular Dysfunction due to Hiatus Hernia
Kazuhiro Nishigami (Department of Critical Care and Cardiology, Saiseikai Kumamoto Hospital, Kumamoto)
APCDE-IIC-5. A Case of Thyrotoxic Heart Disease Showing Marked Cardiomegaly and Severe Right Heart Failure
Nobuo Fukuda (Department of Clinical Research, Nationl Hospital Organazation Zentsuji Hospital, Zentsuji)
※こちらの演題は収録しておりません。
APCDE-IIC-6. A Case of Familial Cardiac Myxoma
Woo-Shik Kim (Kyung Hee University Hospital, Seoul, Korea)
APCDE-IIC-7. Cases in which 3D Transesophageal Echocardiography was Useful for Evaluation of Prosthetic Valve Dysfunction
Kunitsugu Takasaki (Department of Cardiovascular, Respiratory and Metabolic Medicine, Kagoshima University, Kagosima)
APCDE-IIC-8. A Case of Chronic Hypoxemia with Unknown Causes: Usefulness of Contrast Echocardiography
Chisato Izumi (Department of Cardiology, Tenri Hospital, Tenri)
久山町研究50周年記念シンポジウム
HS1. Memorial Lecture (Plenary Session on Special Lecture) on HISAYAMA STUDY “Clinico-Epidemiological and Pathological Studies”
座長:
Chuwa Tei (Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima)
HS1-1. History of Hisayama Study
Teruo Omae (National Cerebral and Cardiovascular Center and Health C&C Center Hisayama, Fukuoka)
HS1-2. Secular Trends And Current Status of Cardiovascular Disease: The Hisayama Study
Yutaka Kiyohara (Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka)
HS1-3. Epidemiological Pathology in the Hisayama Study
Kenzou Tanaka (Fukuoka Dental College, Fukuoka)
HS2. Cardiovascular Epidemiology in the East and the West
座長:
Hirotsugu Yamada (Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima)
Russell V. Luepker (Division of Epidemiology and Community Health School of Public Health, University of Minnesota, Minneapolis, USA)
HS2-1. Cardiovascular Risk Factors in Japanese: The Hisayama Study
Toshiharu Ninomiya (Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka)
HS2-2. The National Integrated Project for Prospective Observation of Non-communicable Diseases and Its Trends in the Aged (NIPPON DATA)
Tomonori Okamura (Department of Preventive Medicine and Public Health, Keio University, Tokyo)
HS2-3. Serum Cholesterol and Risk of Cardiovascular Disease in Korean Men: KMIC Study
Il Suh (Yonsei University College of Medicine, Seoul, Korea)
HS2-4. Cardiovascular Diseases in China: Epidemic and Challenges
Dongfeng Gu (National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
HS2-5. Lifestyle and Longevity: Contributions from the Honolulu Heart Program
Robert Douglas Abbott (Radiation Effects Research Foundation, Hiroshima)
HS2-6. Heart Disease Prediction Past, Present and Future: The Framingham Experience and Beyond
Ralph B. D'Agostino (Boston University Mathematic and Statistics Department, Boston, USA)
※こちらの演題は収録しておりません。
HS2-7. Observational Evidence from the PROGRESS Trial and the APCSC Collaboration: Comparing Data from Asian and Caucasian Subjects
John Chalmers (The George Institute for Global Health, University of Sydney, Sydney, Australia)
HS2-8. Observational studies in Europe. The PAMELA study
Giusepp Mancia (University of Milano-Bicocca, St. Gerardo Hospital, Milan, Italy)
プレナリーセッション
PS1. Plenary Session 1
座長:
Shinya Goto (Department of Cardiovascular Medicine, Tokai University School of Medicine, Isehara)
Louise Bowman (Clinical Trial Service Unit, University of Oxford, Oxford, UK)
PS1-ART. State-of-the-Art:From the View Point of the Antithrombotic Trialists Collaboration
Louise Bowman (Clinical Trial Service Unit, University of Oxford, Oxford, UK)
PS1-1. Low-dose Aspirin Therapy for Primary Prevention of Cardiovascular Events in Type 2 Diabetic Patients: Lesson from the JPAD Trial
Yoshihiko Saito (The First Department of Internal Medicine, Nara Medical University, Kashihara)
PS1-2. Both CYP2C19 and PON1 Genotypes are Associated with Clinical Outcome of Clopidogrel Therapy
Ki-Bae Seung (Seoul St. Mary's Hospital, Seoul, Korea)
PS1-3. Potential Influence of Organ Specificity of Atherothrombosis in Japanese Patients on the Use of Antiplatelet Therapy
Eri Toda (Internal Medicine, Department of Cardiology, Tokai University School of Medicine, Isehara)
PS1-4. Do We Have to Change the Type or Dose of Antiplatelet Agent According to CYP2C19 or 3A5 Genotypes?
Seiji Hokimoto (Department of Cardiovascular Medicine, Kumamoto University, Kumamoto)
PS1-5. Impact of Genotype of Clopidgrel Resistance on Lesion Outcome after Drug-eluting Stent Implantation in Japanese: An Optical Coherence Tomography Analysis
Toshiro Shinke (Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe)
PS2. Plenary Session 2
座長:
Masahiko Kurabayashi (Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi)
Linda L. Demer (University of California, Los Angeles, USA)
PS2-ART. State-of-the-Art:Vascular Calcification and Plaque Rupture
Linda L. Demer (University of California, Los Angeles, USA)
PS2-1. Notch Signaling Mediates RAGE-Induced Vascular Calcification
Masahiko Kurabayashi (Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi)
PS2-2. Vascular Smooth Muscle Cells in the Pathogenesis of Vascular Calcification: Their Distinctive Roles in Plaque Calcification and Medial Calcification
Koji Ikeda (Department of Cardiology, Kyoto Prefectural University of Medicine, Kyoto)
PS2-3. Cross-talk of RANKL Signaling with Renin Angiotensin System in Vascular Calcification
Hironori Nakagami (Division of Vascular Medicine and Epigenetics, Osaka University, Osaka)
PS2-4. Association of Aortic Valve Calcification and Vulnerable Coronary Plaques Assessed by Coronary CT Angiography
Hiroto Utsunomiya (Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima)
PS2-5. Impact of Spotty Calcification on Computed Tomography for Prediction of Cardiac Troponin Elevation after Percutaneous Coronary Intervention
Akira Satoh (Cardiovascular Division, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba)
PS3. Plenary Session 3
座長:
Satoshi Ogawa (International University of Health and Welfare Mita Hospital, Tokyo)
Jean-Yves Le Heuzey (Hopital European Georges Pompidou, Universite Rene Descartes, Paris, France)
PS3-ART. State-of-the-Art:Treatment of Atrial Fibrillation in Heart Failure Patients
Jean-Yves Le Heuzey (Hopital European Georges Pompidou, Universite Rene Descartes, Paris, France)
PS3-1. Impact of Atrial Fibrillation in Advanced Heart Failure Patients Admitted for Acute Decompensation: Perspectives from Single Center Cardiomyopathy Registry
Shun Kohsaka (Department of Cardiology, Keio University School of Medicine, Tokyo)
PS3-2. Intercalated Disk Remodeling and Arrhythmogenesis during the Development of Heart Failure -Its Mechanism and New Upstream Therapy-
Tomoko Ohkusa (Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube)
PS3-3. Sympathetic Denervation Using Stellate Ganglia Ablation as Novel Therapeutic Approach for Cardiac Arrhythmias in Heart Failure
Masahiro Ogawa (Department of Cardiology, Fukuoka University School of Medicine, Fukuoka)
PS3-4. Pharmacological Management for Life-threatening Ventricular Tachyarrhythmias Complicating Severe Heart Failure
Takanori Ikeda (Department of Cardiovascular Medicine, Toho University Medical Center Omori Hospital, Tokyo)
PS3-5. Emergency Catheter Ablation for Ventricular Tachyarrhythmias in Patients with Acute Heart Failure Decompensation
Meiso Hayashi (Divison of Cardiology, Department of Internal Medicine, Nippon Medical School, Tokyo)
※こちらの演題は収録しておりません。
PS3-6. Occurrence and Risks of Life-threatening Arrhythmia in Heart Failure Patients with Cardiac Resynchronization Therap
Tsuyoshi Shiga (Department of Cardiology, Tokyo Women's Medical University, Tokyo)
※こちらの演題は収録しておりません。
PS3-7. Predictor of Lethal Ventricular Tachyarrhythmias after Implantation of Cardiac Resynchronization Therapy with Defibrillator (CRT-D) as Primary Prevention
Shingo Sasaki (Department of Advanced Management of Cardiac Arrhythmias, Hirosaki University Graduate School of Medicine, Hirosaki)
PS4. Plenary Session 4
座長:
許 俊鋭 (東京大学 重症心不全治療開発講座/東京都健康長寿医療センター心臓外科)
筒井 裕之 (北海道大学 循環病態内科学)
PS4-1. Novel Treatment Strategy to Bail Out Low Cardiac Output by Using Tolvaptan in End-Stage Heart Failure
品川 弥人 (北里大学 循環器内科学)
PS4-2. Remodeling during Left Ventricular Assist Devise Support in Endstage Heart Failure and Potential Anti-Remodeling Co-therapy of Natriuretic Peptides
市来 智子 (メイヨークリニック 循環器科)
PS4-3. Early and Mid-term Outcomes of Surgical Ventricular Restoration for Heart Failure Patients with Aeverely Dilated Left Ventricle after Myocardial Infarction
松山 重文 (榊原記念病院 心臓血管外科)
PS4-4. Impact of Left Ventricular Assist Device (LVAD) on Cardiomyopathy with Stage-D Heart Failure: The Experience in a Non-transplant Institution
篠岡 太郎 (東京医科歯科大学 循環器内科)
PS4-5. What Should We Know before Implantation of a Left Ventricular Assist Device (LVAD) in the Era of Continuous Flow Pumps?
絹川 弘一郎 (東京大学 循環器内科学)
PS4-6. Role of Ventricular Assist Devices in the Treatment of Stage D Heart Failure
坂口 太一 (大阪大学 心臓血管外科学)
PS4-7. Serial Changes in Renal Function as a Prognostic Indicator in Advanced Heart Failure Patients with Pulsatile Left Ventricular Assist System
岩嶋 義雄 (国立循環器病研究センター 高血圧・腎臓内科)
PS5. Plenary Session 5
座長:
澤 芳樹 (大阪大学 心臓血管外科)
福田 恵一 (慶應義塾大学 循環器内科)
PS5-1. Endothelial Progenitor Cell Biology in Diseases and Its Therapeutic Strategy
浅原 孝之 (東海大学 再生医療科学)
PS5-2. Distinct Metabolic Flow Enables Large-Scale Purification of Pluripotent Stem Cell-Derived Cardiomyocytes
遠山 周吾 (慶應義塾大学 循環器内科学)
※こちらの演題は収録しておりません。
PS5-3. Impact of Vascular Endothelial Growth Factor-coated Stent on Capturing Endothelial Progenitor Cells: Evidence from in vivo Analysis with Porcine Model
高畠 周 (金沢大学 臓器機能制御学・循環器内科)
PS5-4. A New Era of Cardiac Regeneration Via a Hybrid Cell-therapy Using Autologous Human Cardiac Stem Cell; The ALCADIA Trial
竹原 有史 (旭川医科大学 心血管再生先端医療開発講座)
PS5-5. Translational Research of Cell Sheet-based Myocardial Regeneration Therapy
宮川 繁 (大阪大学 心臓血管外科)
PS6. Plenary Session 6
座長:
Yutaka Otsuji (Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu)
Jae K. Oh (Mayo Clinic, Rochester, USA)
PS6-ART. State-of-the-Art:Can Echocardiography Replace Stethoscope?
Jae K. Oh (Mayo Clinic, Rochester, USA)
PS6-1. Role of Modern 3D Echocardiography in Clinical Cardiology: The Present and the Future
Takahiro Shiota (Cedars-Sinai Medical Center / UCLA (University of California, Los Angeles), Los Angeles, USA)
PS6-2. Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE): Mid-term Results
Masaaki Takeuchi (Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu)
PS6-3. Utility of Parametric Imaging to Identify Myocardial Risk Area by Strain Rate in 3D Adenosine-stress Echocardiography
Masumi Iwai-Takano (Intensive Care Unit, Fukushima Medical University Hospital, Fukushima)
PS6-4. New Developed 3-dimensional Dyssynchrony Imaging by Speckle Tracking Echocardiography
Yoshihiro Seo (Cardiovascular Division, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba)
PS6-5. Papillary Muscle Head Relocation Based on Its Geometric Evaluation by 3D Echocardiography
Kikuko Obase (Department of Cardiology, Kawasaki Medical School, Kurashiki)
PS6-6. Prognostic Value of "Preload Stress Echocardiography" in Patients with Mild Heart Failure
Hirotsugu Yamada (Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima)
PS6-7. Clinical Implications of Real-time Three-dimensional Transesophageal Echocardiography for Catheter Closure of Atrial Septal Defect
Yasufumi Kijima (Department of Cardiovascular Medicine, Okayama University, Okayama)
PS7. Plenary Session 7
座長:
井上 博 (富山大学 第二内科)
宮田 昌明 (鹿児島大学 循環器・呼吸器・代謝内科学)
PS7-1. Effect of Waon Therapy on Autonomic Nervous Activity in Chronic Heart Failure
桑波田 聡 (鹿児島市医師会病院 循環器内科)
PS7-2. Effects of Waon Therapy on Multiple Organ Dysfunction in Patients with Chronic Heart Failure
島田 和典 (順天堂大学 循環器内科学)
PS7-3. Effect of Waon Therapy on Vasospastic Angina
石井 克尚 (関西電力病院 循環器内科)
PS7-4. Waon Therapy Improves Myocardial Perfusion in Patients with Severe Coronary Lesions
傍島 光男 (富山大学 第二内科)
PS7-5. Effects of Waon Therapy on Autonomic Nervous Activity and Oxidative Stress Associated with Endothelial Dysfunction in Patients with Arteriosclerosis Obliterans
野田 千春 (北里大学 循環器内科学)
PS7-6. Molecular Mechanism of Waon Therapy on Cardiovascular Disease
赤﨑 雄一 (鹿児島大学 循環器・呼吸器・代謝内科学)
シンポジウム
SY1. Symposium 1
座長:
木村 剛 (京都大学医学部附属病院 循環器内科学)
高梨 秀一郎 (榊原記念病院 心臓血管外科)
SY1-1. Five-year Clinical Outcome of Gen-1 DES in Japanese Population: Data from Japan Post-marketing Surveillance Study for Cypher?
小谷 順一 (国立循環器病研究センター 心臓血管内科)
SY1-2. Six-year Outcomes after Coronary Artery Bypass Grafting in Patients with Left Main Disease
福井 寿啓 (榊原記念病院 心臓血管外科)
SY1-3. The Outcomes of the Dominance of Cross over Strategy for the Un-protected Left Main Coronary Artery
田山 信至 (熊本大学 循環器病態学)
SY1-4. Percutaneous Coronary Intervention with Drug-eluting Stent and Bypass Surgery for Patients with Unprotected Left Main Coronary Artery Disease
福 康志 (倉敷中央病院 循環器内科)
SY1-5. Juntendo Revascularization Registry in Diabetes: Long-Term Outcomes of Off-pump Coronary Artery Bypass Grafting Versus Sirolimus-Eluting Stent with Multivessel Coronary Disease
梶本 完 (順天堂大学医学部附属浦安病院 心臓血管外科)
SY1-6. Comparison of Three-year Outcome After PCI and CABG in Patients with Triple-vessel Disease: Insight from the CREDOKyoto PCI/CABG Registry Cohort-2
塩見 紘樹 (京都大学 循環器内科学)
SY3. Symposium 3
座長:
室原 豊明 (名古屋大学 循環器内科学)
佐田 政隆 (徳島大学 循環器内科学)
SY3-1. Towards Development of New Biomarkers of Atherosclerosis ― Use of New Proteomic Technologies
鈴木 亨 (東京大学 循環器内科・ユビキタス予防医学講座)
※こちらの演題は収録しておりません。
SY3-2. Lipoprotein-associated Phospholipase A2 Related to the Risk of Subclinical Carotid Atherosclerosis in a General Male Japanese Population
上島 弘嗣 (滋賀医科大学 生活習慣病予防センター)
※こちらの演題は収録しておりません。
SY3-3. Diagnosis and Assessment of Takayasu Arteritis by Multiple Biomarkers
磯部 光章 (東京医科歯科大学 循環制御内科学)
※こちらの演題は収録しておりません。
SY3-4. Inflammatory Biomarkers as Predictors of Vulnerable Coronary Plaques
添木 武 (徳島大学 循環器内科学)
SY3-5. Omentin Acts a Novel Biomarker for Atherosclerotic Cardiovascular Disease
大内 乗有 (名古屋大学 分子循環器学)
SY3-6. Impact Of Simultaneous Determination Of Early and Late Endothelial Progenitor Cells On Evaluation Of Coronary Artery Diseases
坪川 俊成 (金沢大学 臓器機能制御学・循環器内科)
SY5. Symposium 5
座長:
増山 理 (兵庫医科大学 循環器内科)
木佐貫 彰 (鹿児島大学 保健学科)
SY5-1. Underlying Cause and Functional Importance of Left Ventricular Long Axis Dysfucntion in Heart Failure with Preserved Ejection Fraction
石津 智子 (筑波大学 循環器内科)
SY5-2. Diastolic Dysfunction Manifests as Loss of Adrenergic Augmentation of Apical Suction
大原 貴裕 (国立循環器病研究センター 心臓血管内科)
SY5-3. Left Ventricular Systolic Dysfunction Plays a Significant Role in the Development of Heart Failure with Preserved Ejection Fraction in Hypertension
河野 美穂子 (鹿児島大学 循環器・呼吸器・代謝内科学)
SY5-4. The Impact of Hypertension and Anemia on Heart Failure Patients with Preserved Ejection Fraction is Dismissed in Very Elderly Patients
平井 雅之 (鳥取大学 病態情報内科学)
SY5-5. Aortic Stiffening and Endothelial Dysfunction Account for Exercise Intolerance in Patients with Heart Failure Preserved Ejection Fraction
正木 充 (兵庫医科大学 循環器内科学)
SY5-6. Incremental Prognostic Significance of Peripheral Endothelial Dysfunction in Patients with Heart Failure with Normal Left Ventricular Ejection Fraction
秋山 英一 (横浜市立大学 市民総合医療センター 心臓血管センター)
※こちらの演題は収録しておりません。
SY5-7. A New Treatment Strategy for Heart Failure with Preserved Ejection Fraction Patients by Introducing Cardiac Rehabilitations
高橋 啓 (日本医科大学 循環器内科)
SY6. Symposium 6
座長:
Ryozo Nagai (Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo)
Yigal M. Pinto (Academic Medical Center Amsterdam, Amsterdam, The Netherlands)
SY6-KEY. Keynote Lecture:Biomarkers in Cardiac Disease: Protein Biomarkers and Circulating MicroRNAs
Yigal M. Pinto (Academic Medical Center Amsterdam, Amsterdam, The Netherlands)
※こちらの演題は収録しておりません。
SY6-1. Undestanding the Role of MicroRNAs in Cardiovascular Diseases
Gianluigi Condorelli (National Research Council of Italy, Milan, Italy)
SY6-2. Circulating MicroRNAs may Predict Future Cardiac Remodeling and Heart Failure in Patients after Acute Myocardial Infarction
Yasuhiko Sakata (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita)
SY6-3. Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients with Cardiovascular Disease Indicate the Existence of Myocardial Damage
Koh Ono (Department of Cardiovascular Medicine, Kyoto University Gradualte School of Medicine, Kyoto)
SY6-4. Rho-kinase Activity in Circulating Leukocytes as a Novel Biomarker in Patients with Chronic Heart Failure
Zhulan Qiqige (Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai)
SY6-5. Caveolae-related Genes in Heart Failure and Arrhythmia
Tomomi Ueyama (Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto)
SY8. Symposium 8
座長:
Issei Komuro (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka)
Thomas Eschenhagen (Department of Experimental Pharmacology and Toxicology, University Medical Centre Hamburg Eppendorf, Hamburg, Germany)
SY8-KEY. Keynote Lecture:Development of a Pharmacological Approach to Myocardial Regeneration
Mark Mercola (Sanford Burnham Medical Research Institute, La Jolla, USA)
SY8-1. Myocardial Tissue Engineering as Improved in Vitro Test Beds
Thomas Eschenhagen (Department of Experimental Pharmacology and Toxicology, University Medical Centre Hamburg Eppendorf, Hamburg, Germany)
※こちらの演題は収録しておりません。
SY8-2. Bio Rapid Prototyping Project for Cardiovascular Regeneration: A Simple Method to Build Scaffold Free Living 3D Micro Patterned Cell Construct
Koichi Nakayama (Biomedical Engineering Course Advanced Technology Fusion, Graduate School of Science and Engineering, Saga University, Fukuoka)
※こちらの演題は収録しておりません。
SY8-3. Developing Translational Research of iPS Cell-Derived Cardiac Progenitor Cell-Sheet Transplantation for Treating Advanced Cardiac Failure
Satsuki Fukushima (Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka)
SY8-4. The Establishment of Analysis Methods and Novel Therapies for Cardiovascular Diseases Syndrome Using Human iPS Cells
Shinsuke Yuasa (Department of Cardiology, Keio University School of Medicine, Tokyo)
※こちらの演題は収録しておりません。
SY14. Symposium 14
座長:
天野 惠子 (静風荘病院)
瀧原 圭子 (大阪大学保健センター)
SY14-1. Recent Trends of Cardiovascular Disease in Women. A TwentyFour Year Analysis of the Patients Hospitalized for Coronary Care Unit
哲翁-塚田 弥生 (日本医科大学 循環器内科)
SY14-2. Sex Differences and Outcome of Witnessed Patients with Out-ofhospital Cardiac Arrest: Impact of Prehospital Advanced Life Support Procedures
小島 淳 (日本循環器学会 蘇生科学小委員会)
SY14-3. Prevention of Subclinical Atherosclerosis: Search for Genderspecific Risk Factors and Salutary Interventions Against its Progression
真田 昌爾 (大阪大学 保健センター)
SY14-4. Microvascular Angina in Menopausal Women
福島 聖二 (日本大学 練馬光が丘病院 循環器科)
SY14-5. Acetylcholine-provoked Diffuse Coronary Spasm is Frequently Observed in Female Patients with Coronary Vasospastic Angina without Severe Coronary Organic Stenosis
海北 幸一 (熊本大学 循環器病態学)
SY14-6. Gender Differences in Clinical Characteristics and Outcomes of Patients with Vasospastic Angina -A Report from the Japanese Coronary Spasm Association-
川名 暁子 (東北大学 循環器内科学)
SY14-7. Clinical Perspectives from Sex Based Analysis in Patients with Acute Myocardial Infarction
松本 専 (大阪大学 循環器内科学)
※こちらの演題は収録しておりません。
SY14-8. CD4 T Cell Dysfunction in Perimenopausal Women
佐藤 加代子 (東京女子医科大学 循環器内科)
SY14-9. Gender Differences in Correlation Between Chronic Kidney Disease with Left Ventricular Hypertrophy and Remodeling
嘉川 亜希子 (鹿児島大学 循環器・呼吸器・代謝内科学)
SY14-10. Sex-related Differences in Japanese Patients with Peripheral Arterial Disease
熊倉 久夫 (北関東循環器病院 内科)
SY15. Symposium 15
座長:
Yoshihiko Saito (First Department of Internal Medicine, Nara Medical University, Nara)
Donald S. Silverberg (Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel)
SY15-KEY. Keynote Lecture:The Cardio Renal Anemia Syndrome
Donald S. Silverberg (Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel)
SY15-1. The Kidney Heart Connection: Role of the Natriuretic Peptides from Diagnostics to Therapeutics
John C. Burnett (Mayo Clinic, Rochester, USA)
SY15-2. Novel Mechanisms of Anti-atherogenic Effect by Soluble Flt-1 in CKD Patients
Yukiji Taked (The First Department of Internal Medicine, Nara Medical University, Nara)
SY15-3. Epigenetics of Tissue Renin-angiotensin-aldosterone System in Cardiorenal Syndrome
Yoshiyu Takeda (Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa)
SY15-4. Renal Collecting Duct Epithelial Cells Regulate Cardiovascular Renal Connection
Katsuhito Fujiu (Department of Cardiovascular Medicine, The University of Tokyo, Tokyo)
SY16. Symposium 16
座長:
Kiyoshi Yoshida (Department of Cardiology, Kawasaki Medical School, Okayama)
Catherine M. Otto (University of Washington School of Medicine, Seattle, USA)
SY16-KEY. Keynote Lecture:Calcific Valve Disease: Causes and Consequences
Catherine M. Otto (University of Washington School of Medicine, Seattle, USA)
SY16-1. Surgery Versus Conventional Treatment in Elderly Patients with Aortic Stenosis
Takashi Kubo (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama)
※こちらの演題は収録しておりません。
SY16-2. The Surgical Result of Valvular Heart Disease in Consecutive 195 Patients for Octogenarians and Nonagenarians
Takeki Ohhashi (Nagoya Tokushukai General Hospital, Aichi)
SY16-3. Transcatheter Aortic Valve Implantation for High-risk Patients with Aortic Stenosis
Kei Torikai (Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka)
SY16-4. Calcific Extension towards the Mitral Valve in Degenerative Aortic Stenosis Causes Non-Rheumatic Mitral Stenosis: Real-Time 3D Transesophageal Echocardiography Study
Kyoko Otani (Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu)
SY16-5. Prognosis of Conservatively Treated Elderly Patients with Severe Organic Mitral Regurgitation
Hiroyuki Okura (Division of Cardiology, Kawasaki Medical School, Kurashiki)
SY17. Symposium 17
座長:
下川 宏明 (東北大学 循環器内科学)
伊藤 正明 (三重大学 循環器・腎臓内科学)
SY17-1. Interventions to the Imbalance of BMP/TGF-β Signal in PAH - A Potential Treatment for Vascular Remodeling from Genetic Studies -
大郷 剛 (国立循環器病研究センター 心臓血管内科)
※こちらの演題は収録しておりません。
SY17-2. Enhancement of Apoptosis as a Novel Therapeutic Strategy for Idiopathic Pulmonary Arterial Hypertension
中村 一文 (岡山大学 循環器内科学)
SY17-3. Reduced BMPR-II Induces GM-CSF Translation by Impaired Stress Granule Response, Exacerbating Pulmonary Hypertension
澤田 博文 (三重大学 麻酔集中治療学)
SY17-4. Acute Response to PDE5 Inhibitor on Pulmonary Hemodynamics as Prognostic Marker for Long-term Survival of Patients with Pulmonary Arterial Hypertension
竹内 和彦 (浜松医科大学 臨床薬理学)
SY17-5. Future Potential of Imatinib for the Treatment of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
八尾 厚史 (東京大学 循環器内科)
SY17-6. Recent Progress in the Management of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
福本 義弘 (東北大学 循環器内科学)
SY17-7. The Efficacy and the Safety of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
下川原 裕人 (岡山医療センター 循環器科)
SY17-8. Percutaneous Transluminal Pulmonary Angioplasty is Useful for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
片岡 雅晴 (杏林大学 第二内科)
SY21. Symposium 21
座長:
井上 晃男 (獨協医科大学 心臓・血管内科)
平田 健一 (神戸大学 循環器内科学)
SY21-1. Chronic Inflammation in Homeostasis and Pathology in Cardiometabolic Syndrome and Chronic Kidney Disease
眞鍋 一郎 (東京大学 循環器内科)
SY21-2. Immunoregulatory Cytokine-mediated Inhibition of Vascular Inflammation in Atherosclerosis
平瀬 徹明 (国立循環器病研究センター研究所 分子生物学部)
SY21-3. Regulation of Inflammation via Modulating Intestinal Immunity for Prevention of Atherosclerotic Cardiovascular Diseases
山下 智也 (神戸大学 循環器内科学)
SY21-4. Delayed Inflammatory Response after Drug-eluting Stent Implantation
阿部 七郎 (獨協医科大学 心臓・血管内科)
SY21-5. Nasal Vaccine against Outer Membrane Protein of Periodontal Bacteria Suppressed the Bacteria-induced Atherosclerosis
大口 純人 (日本大学松戸歯学部 内科)
SY21-6. Mast Cell-mediated Inflammation Promotes Atrial Fibrillation in Stressed Hearts
赤澤 宏 (大阪大学 循環器内科学)
SY21-7. Modulation of Toll-like Receptor 2 on Chronic Inflammation in Patients with Atherosclerosis and Atrial Fibrillation
折原 弘治 (鹿児島大学 循環器・呼吸器・代謝内科学)
ラウンドテーブルディスカッション2
座長:
牧田 茂 (埼玉医科大学国際医療センター 心臓リハビリテーション科)
池田 久雄 (久留米大学医療センター 循環器内科)
RD2-KEY. Keynote Lecture:Indications for Exercise Training in Patients with Intermittent Claudication
太田 敬 (愛知医科大学 血管外科)
RD2-1. Risk Perception Regarding Cardiovascular Disease and Health Behavior among Patients with Peripheral Arterial Disease
大野 和美 (天使大学 看護栄養学部 看護学科)
RD2-2. Evidence of Exercise Training for Peripheral Arterial Disease
安 隆則 (琉球大学 循環器・腎臓・神経内科学)
RD2-3. The Role of Comprehensive Cardiac Rehabilitation in Patients with Peripheral Artery Disease after Endovascular Intervention
横井 宏佳 (小倉記念病院 循環器内科)
RD2-4. Effect of Waon Therapy for Peripheral Artery Disease
新里 拓郎 (鹿児島大学 循環器・呼吸器・代謝内科学)
トピックス
TP3. Topic 3
座長:
佐渡島 純一 (University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, USA)
牧野 直樹 (九州大学病院別府病院)
TP3-1. Mitochondria at the Crossroad of Metabolic Stress and Cardiovascular Aging
新村 健 (慶應義塾大学 老年内科)
TP3-2. Molecular Mechanism of Vascular Aging : Impact of Vascular Calcification Associated with Cellular Senescence
飯島 勝矢 (東京大学 高齢社会総合研究機構)
TP3-3. Lifespan Regulatory System and Cardiovascular Disease
南野 徹 (千葉大学 循環病態医科学)
TP3-4. Waon Therapy, a Form of Thermal Therapy, Retards Arterial Aging via Upregulation of Sirt-1 in Apolipoprotein E-Deficient Mouse
池田 義之 (鹿児島大学 循環器・呼吸器・代謝内科学)
TP5. Topic 5
座長:
下川 宏明 (東北大学 循環器内科学)
濱崎 秀一 (鹿児島大学 循環器・呼吸器・代謝内科学)
TP5-1. Significance of Coronary Vasospasm in Coronary Artery Disease
海北 幸一 (熊本大学 循環器病態学)
TP5-2. Possible Usefulness of Rho-kinase Activity in Circulating Neutrophils for Disease Activity Assessment of Vasospastic Angina
安田 聡 (国立循環器病研究センター 心臓血管内科部門)
TP5-3. Diagnosis of Coronary Vasospasm by Detection of Post-ischemic Diastolic Stunning Using 3D Speckle Tracking Echocardiography
石井 克尚 (関西電力病院 循環器科)
TP5-4. Optical Coherence Tomography for Coronary Vasospasm
田中 篤 (紀南病院 循環器科)
TP5-5. Characteristics and Prognosis of Patients with Urgent Vasospastic Angina
西垣 和彦 (岐阜大学 循環病態学)
TP7. Topic 7
座長:
前村 浩二 (長崎大学 循環病態制御内科学)
江本 憲昭 (神戸薬科大学 臨床薬学研究室)
TP7-1. Circadian Clock and Cardiovascular Diseases-Overview
前村 浩二 (長崎大学 循環病態制御内科学)
TP7-2. Clock Abnormality in the Pathogenesis of the Cardiovascular Dysfunction
江本 憲昭 (神戸薬科大学 臨床薬学研究室)
TP7-3. Cardiovascular Aging and Circadian Clock
南野 徹 (千葉大学 循環病態医科学)
TP7-4. A Noninvasive Method for Assessing the Human Clock
明石 真 (山口大学時間学研究所 時間生物学研究室)
TP7-5. Chronopharmacology Based on Molecular Clock
大戸 茂弘 (九州大学大学院薬学研究院 薬剤学)
TP9. Topic 9
座長:
許 俊鋭 (東京大学 重症心不全治療開発講座/東京都健康長寿医療センター心臓外科)
小野 稔 (東京大学医学部附属病院 心臓外科)
TP9-1. What Should We Do for Appropriate Dissemination of Implantable Ventricular Assist Device Treatment?
小野 稔 (東京大学医学部附属病院 心臓外科)
TP9-2. Current Status and Perspectives on Implantable Artificial Hearts: NCVC Experience
中谷 武嗣 (国立循環器病研究センター病院 移植部)
TP9-3. Role of Left Ventricular Assist Devices in Patients with Severe Heart Failure
澤 芳樹 (大阪大学 心臓血管外科学)
TP9-4. Current Stratus on Artifical Heart: Experience as Cardiologists in a Nontransplant Institute
磯部 光章 (東京医科歯科大学 循環制御内科学)
※こちらの演題は収録しておりません。
TP11. Topic 11
座長:
天野 惠子 (静風荘病院)
寺本 民生 (帝京大学 内科学講座)
TP11-1. Impact of Dyslipidemia and Metabolic Syndrome on Cardiovascular Disease for the Elderly and Women: From Community-based Cohort Studies in Japa
岡村 智教 (慶應義塾大学 衛生学公衆衛生学)
TP11-2. Lipid Management in Metabolic Syndrome
朔 啓二郎 (福岡大学 心臓・血管内科学 心臓・血管内科学)
TP11-3. Control of Dyslipidemia in Japanese Women
佐久間 一郎 (カレスサッポロ北光記念クリニック 内科)
TP11-4. Control of Dyslipidemia in the Elderly
大内 尉義 (東京大学 加齢医学講座)
コントロバーシー
CON1.Controversy 1
座長:
桑島 巌 (東京都健康長寿医療センター)
菊池 健次郎 (北海道循環器病院)
CON1-1. Significance of Pleiotropic Effects of ARBs in Cardiovascular Protection
光山 勝慶 (熊本大学 生体機能薬理学)
CON1-2. ACE Inhibitors are Better than ARBs.: Controversies in Coronary Artery Disease
伊藤 浩 (岡山大学 循環器内科学)
CON1-3. Yes. There was a Blood Pressure-independent Cardioprotection Effect
久代 登志男 (日本大学医学部 総合健診センター)
CON1-4. From Standpoint of View that There is No Cardioprotective Effect beyond Blood Presssure in ARB
桑島 巌 (東京都健康長寿医療センター 循環器科)
CON4.Controversy 4
座長:
犀川 哲典 (大分大学 臨床検査診断学講座(循環器内科))
新 博次 (日本医科大学多摩永山病院)
CON4-1. Japan Original Evidence of Warfarin Therapy in Patients with Atrial Fibrillation
高橋 尚彦 (大分大学 臨床検査・診断学講座)
CON4-2. Xa Blocker for Anticoagulation Therapy in Atrial Fibrillation
熊谷 浩一郎 (国際医療福祉大学大学院 福岡山王病院ハートリズムセンター)
CON4-3. Advocating for Anti-thrombin Drugs
山下 武志 (心臓血管研究所 循環器内科)
CON4-4. Warfarin is Still Considered to be an Anticoagulant Agent as the First Choice in Patients with Non-valvular Atrial Fibrillation
小松 隆 (岩手医科大学 心血管・腎・内分泌内科分野)
ミート・ザ・エキスパート
ME2.Meet the Expert 2
座長:
Pravin M. Shah (Hoag Heart and Vascular Institute, Newport Beach, USA)
Yukikatsu Okada (Kobe City Medical Center General Hospital, Kobe)
ME2-KEY. Keynote Lecture:Repair Options for Barlow's Valve
Aidan A. Raney (Hoag Heart and Vascular Institute, Newport Beach, USA)
※こちらの演題は収録しておりません。
ME2-1. The Techniques and Potential Pitfalls in Mitral Valve Repair Surgery Using Artificial Chords to Repair a Posterior Mitral Prolapse
Kazuo Tanemoto (Department of Cardiovascular Surgery, Kawasaki Medical School, Kurashiki)
ME2-2. Restoration of the Mitral Valve Structures
Kiyoyuki Eishi (Department of Cardiovascular Surgery, Nagasaki University School of Medicine, Nagsaki)
ME2-3. Recurrent MR and Newly Developing Functional MS Following Surgical Annuloplasty for Ischemic MR
Yutaka Otsuji (Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu)
ME3.Meet the Expert 3
座長:
Keijiro Saku (Department of Cardiology, Fukuoka University School of Medicine, Fukuoka)
Moti L. Kashyap (Atherosclerosis Research Center, Department of Veterans Affairs Medical Center, Long Beach, California / Department of Medicine, University of California, Irvine, USA)
ME3-1. Mechanism of Action of Niacin: Gateway to New Therapeutic Targets for HDL and Beyond
Moti L. Kashyap (Atherosclerosis Research Center, Department of Veterans Affairs Medical Center, Long Beach, California / Department of Medicine, University of California, Irvine, USA)
ME3-2. Targeting ABCA1 for Raising HDL
Shinji Yokoyama (Food and Nutritional Sciences, Chubu University, Kasugai)
ME3-3. Current Status and Future Perspective of CETP Inhibitors
Katsunori Ikewaki (Division of Anti-Aging, Department of Internal Medicine, National Defense Medical College, Saitama)
ME3-4. HDL-Apo A-I Mimetic Peptide (FAMP): Tools for Imaging and Therapy for Atherosclerosis
Keijiro Saku (Department of Cardiology, Fukuoka University School of Medicine, Fukuoka)
ME7.Meet the Expert 7
座長:
廣江 道昭 (国立国際医療研究センター病院 循環器内科)
森本 紳一郎 (藤田保健衛生大学 循環器内科)
ME7-1. Contribution of Heart Pathology to Clinical Cardiovascular Research
由谷 親夫 (岡山理科大学 理学部臨床生命科学科)
ME7-2. Morphology Revisited in Cardiovascular Science
竹村 元三 (岐阜大学 循環器内科学)
ME7-3. Application of Endomyocardial Biopsy for the Treatment of Secondary Cardiomyopathy
矢崎 善一 (まつもと医療センター松本病院 循環器科)
ME7-4. Cardiac Fabry Disease
竹中 俊宏 (鹿児島大学 心筋症病態制御講座)
ME7-5. Pompe Disease
市田 蕗子 (富山大学 小児科)
ME7-6. Imaging Mass Spectrometry: A New Technology for a Diagnosis of Cardiovascular Diseases
尾上 健児 (奈良県立医科大学 循環器・腎臓・代謝内科)
スペシャルモーニングレクチャー
座長:
齋藤 穎 (敬愛病院/日本大学)
SML. Clinical Implication of the Developments in Cardiovascular Imaging
児玉 和久 (大阪警察病院/尼崎中央病院 心臓血管センター)
Late Breaking Clinical Trials
LBCT1.Late Breaking Clinical Trials 1
座長:
髙本 眞一 (三井記念病院)
山岸 正和 (金沢大学 臓器機能制御学・循環器内科)
LBCT1-1. Clinical Efficacy of Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis in High Risk Patients: PREVAIL JAPAN Trial
澤 芳樹 (PREVAIL JAPAN Study Group 大阪大学 心臓血管外科・先進治療医学)
LBCT1-1.
尾辻 豊 (産業医科大学 第 2 内科学)
LBCT1-2. Initial and Long-term Clinical Outcome of Primary Stenting for Aortiliac Artery Disease
曽我 芳光 (小倉記念病院 循環器内科)
※こちらの演題は収録しておりません。
LBCT1-2.
古森 公浩 (名古屋大学 血管外科)
LBCT1-3. Diagnostic Ability of Remote Monitoring System for the Follow-up of Implantable Cardioverter Defibrillator Patients: Japan Home Monitoring (J-HOME ICD) Study
渡邉 英一 (藤田保健衛生大学 循環器内科学)
LBCT1-3.
清水 昭彦 (山口大学 保健学系学域)
LBCT1-4. Speckle Tracking Imaging for the Assessment of Cardiac Resynchronization Therapy (START) Study
庄田 守男 (東京女子医科大学 循環器内科)
LBCT1-4.
瀬尾 由広 (筑波大学 循環器内科)
LBCT1-5. Prevention of Myocardial Injury with Short-period and High-dose Statin During Coronary Intervention: PRIMITIVE Study
高野 仁司 (日本医科大学 循環器内科)
※こちらの演題は収録しておりません。
LBCT1-5.
代田 浩之 (順天堂大学 循環器内科学)
LBCT2.Late Breaking Clinical Trials 2
座長:
島田 和幸 (自治医科大学 循環器内科)
永井 良三 (東京大学 循環器内科)
LBCT2-1. Antihypertensive Therapy and Cognitive Function - Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial -
長谷部 直幸 (旭川医科大学 循環・呼吸・神経病態内科)
LBCT2-1.
石光 俊彦 (獨協医科大学 循環器内科)
LBCT2-2. The Impact of Valsartan on Adipocytokines in Hypertensive Patients with Metabolic Syndrome
宮田 昌明 (鹿児島大学 循環器・呼吸器・代謝内科学)
LBCT2-2.
代田 浩之 (順天堂大学 循環器内科学)
LBCT2-3. Effects of Losartan/hydrochlorothiazide Combination and Highdose Losartan on Morning Hypertension -A Prospective, Randomized, Open-labeled, Multicenter Trial-
甲斐 久史 (久留米大学 心臓・血管内科)
LBCT2-3.
苅尾 七臣 (自治医科大学 循環器内科学部門)
LBCT2-4. Comparison of Long- and Short-acting Loop Diuretics in Congestive Heart Failure
増山 理 (兵庫医科大学 内科学循環器内科)
LBCT2-4.
百村 伸一 (自治医科大学附属さいたま医療センター 循環器科)
LBCT2-5. A Randomized Controlled Trial of the Comparison of the Cardiac Function between Right Ventricular Septal and Apical Pacing
平山 康高 (北海道循環器病院 循環器科)
※こちらの演題は収録しておりません。
LBCT2-5.
庄田 守男 (東京女子医科大学 循環器内科)
LBCT3.Late Breaking Clinical Trials 3
座長:
相澤 義房 (立川メディカルセンター 研究開発部)
伊藤 隆之 (名城病院)
LBCT3-1. Apixaban Versus Warfarin in Patients with Atrial Fibrillation -Sub-analysis in Japanese Patients in ARISTOTLE Study-
後藤 信哉 (東海大学 循環器内科学)
LBCT3-1.
小川 久雄 (熊本大学 循環器病態学)
LBCT3-2. Safety/Efficacy of Rivaroxaban for Prevention of Stroke in Japanese Atrial Fibrillation Patients - Sub-analysis of Renal Impairment in J-ROCKET AF
堀 正二 (大阪府立成人病センター)
LBCT3-2.
山下 武志 (心臓血管研究所付属病院)
LBCT3-3. The East Japan Earthquake Disaster and Cardiovascular Diseases
下川 宏明 (東北大学 循環器内科学)
LBCT3-3.
伊藤 宏 (秋田大学 循環器内科学)
LBCT3-4. Can Coronary Plaque Volume Change Predict Future Cardiovascular Events? - Extended JAPAN-ACS Study -
宮内 克己 (順天堂大学 循環器内科)
LBCT3-4.
森野 禎浩 (岩手医科大学 循環器内科)
LBCT3-5. Lifestyle Changes Through the Use of Delivered Meals and Dietary Counseling in a Single-Blind Study: The STYLIST Study
朔 啓二郎 (福岡大学 心臓・血管内科学)
LBCT3-5.
大屋 祐輔 (琉球大学 循環器・腎臓・神経内科学)
開会式・閉会式
ページのトップへ